Changes of TGFβ1 and TGFβRII expression in esophageal precancerous and cancerous lesions: A study of a high-risk population in Henan, northern China

Diseases of the Esophagus

Volumn 15, Issue 1, 2002, Pages 74-79

  Zhou, Q ^a   Wang, L Dong ^a,b   Du, F ^a   Zhou, Y ^c   Zhang, Y Rui ^d   Liu, B ^e   Feng, C Wei ^a   Gao, S Shan ^a   Fan, Z Min ^a   Yang, C S ^f   Zheng, S ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d Henan Province Hospital   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EOSIN; HEMATOXYLIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2 RECEPTOR; UNCLASSIFIED DRUG; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL PROLIFERATION; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE COURSE; DISEASE SEVERITY; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; LINEAR SYSTEM; MALE; NEGATIVE FEEDBACK; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SAMPLER; SQUAMOUS CELL CARCINOMA; STAIN; STATISTICAL SIGNIFICANCE; SYMPTOM; TISSUE DISTRIBUTION; TISSUE SECTION; CARCINOMA; CELL TRANSFORMATION; COMPARATIVE STUDY; CULTURE TECHNIQUE; EPIDEMIOLOGY; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PROBABILITY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CULTURE TECHNIQUES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROBABILITY; PROSPECTIVE STUDIES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL;

EID: 0036317039     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2002.00227.x     Document Type: Article

References (26)

1. Research on esophageal cancer in China: A review
2. Cancer mortality and mortality trends in Henan, China, 1974-85
3. Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on the Transkei, South Africa
4. The epidemiology of cancer of the esophagus
5. Precursor lesions of esophageal cancer in high-risk populations in Henan province
6. Labeling index and labeling distribution of cells in esophageal epithelium of individuals at increased risk for esophageal cancer in Huixian, China
7. Precursors of gastric and esophageal cancer
8. Accumulation of P53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis
9. Changes in P53 and cyclin D1 protein level and cell proliferation in different stages of Human esophageal and gastric-cardiac carcinogenesis
10. TGF-β and cancer
11. Invasion and metastasis of a mammary tumor involves TGF-β signaling
12. Abberant cell cycle progression contributes to the early-stage accelerate carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRII
13. A dominant negative mutation growth factor-beta receptor type II gene in microsatellite stable esophageal carcinoma
14. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
15. The transforming growth factor-β family
16. Expression of growth factors and their receptor in human esophageal carcinoma: Regulation of expression by epidermal growth factor and transforming growth alpha
17. Inactivation of the type II TGF-βII receptor in colon cancer cells with microsatellite instability
18. Genomic structure of the transforming growth factor-β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers
19. Growth inhibition by transforming beta (TGF-beta) type is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA
20. A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasmas
21. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasm, and esophageal carcinomas, but not in gastric neoplasm
22. Phosphorylation of ser465 and ser467 in the terminus of Smad2 mediates interaction with Smad4 and is required for TGFβ signaling
23. Loss of transforming growth factor-beat type II receptor gene expression in primary human esophageal cancer
24. Missense mutation of the transforming growth factor-β type II receptor in human head and neck squamous carcinoma cells
25. Characterization of the promoter region of the human transforming growth factor-β type II receptor gene
26. A randomized double-blind intervention study on the effect of calcium supplementation on esophageal precancerous lesions in a high-risk population in China